Impact of the Extended Thrombolysis Time Window on the Proportion of Recombinant Tissue-Type Plasminogen Activator-Treated Stroke Patients and on Door-to-Needle Time - Minnerup, J; Wersching, H; Ringelstein, E B (Stroke, 2011)
et al.